120 related articles for article (PubMed ID: 26858719)
1. Prospective Clinical Testing of Regulatory Dendritic Cells in Organ Transplantation.
Thomson AW; Zahorchak AF; Ezzelarab MB; Butterfield LH; Lakkis FG; Metes DM
Front Immunol; 2016; 7():15. PubMed ID: 26858719
[TBL] [Abstract][Full Text] [Related]
2. Regulatory dendritic cells for promotion of liver transplant operational tolerance: Rationale for a clinical trial and accompanying mechanistic studies.
Thomson AW; Humar A; Lakkis FG; Metes DM
Hum Immunol; 2018 May; 79(5):314-321. PubMed ID: 29100944
[TBL] [Abstract][Full Text] [Related]
3. Donor-derived regulatory dendritic cell infusion results in host cell cross-dressing and T cell subset changes in prospective living donor liver transplant recipients.
Macedo C; Tran LM; Zahorchak AF; Dai H; Gu X; Ravichandran R; Mohanakumar T; Elinoff B; Zeevi A; Styn MA; Humar A; Lakkis FG; Metes DM; Thomson AW
Am J Transplant; 2021 Jul; 21(7):2372-2386. PubMed ID: 33171019
[TBL] [Abstract][Full Text] [Related]
4. Regulatory dendritic cell therapy in organ transplantation.
Hadjiyannis Y; Thomson AW
Curr Opin Organ Transplant; 2024 Apr; 29(2):121-130. PubMed ID: 37991065
[TBL] [Abstract][Full Text] [Related]
5. Generation and functional assessment of nonhuman primate regulatory dendritic cells and their therapeutic efficacy in renal transplantation.
Thomson AW; Ezzelarab MB
Cell Immunol; 2020 May; 351():104087. PubMed ID: 32197811
[TBL] [Abstract][Full Text] [Related]
6. Donor-derived regulatory dendritic cell infusion modulates effector CD8
Tran LM; Macedo C; Zahorchak AF; Gu X; Elinoff B; Singhi AD; Isett B; Zeevi A; Sykes M; Breen K; Srivastava A; Ables EM; Landsittel D; Styn MA; Humar A; Lakkis FG; Metes DM; Thomson AW
Sci Transl Med; 2023 Oct; 15(717):eadf4287. PubMed ID: 37820009
[TBL] [Abstract][Full Text] [Related]
7. Regulatory dendritic cells for human organ transplantation.
Thomson AW; Metes DM; Ezzelarab MB; Raïch-Regué D
Transplant Rev (Orlando); 2019 Jul; 33(3):130-136. PubMed ID: 31130302
[TBL] [Abstract][Full Text] [Related]
8. Manufacturing and validation of Good Manufacturing Practice-compliant regulatory dendritic cells for infusion into organ transplant recipients.
Zahorchak AF; DeRiggi ML; Muzzio JL; Sutherland V; Humar A; Lakkis FG; Hsu YS; Thomson AW
Cytotherapy; 2023 Apr; 25(4):432-441. PubMed ID: 36639251
[TBL] [Abstract][Full Text] [Related]
9. Regulatory dendritic cell therapy: from rodents to clinical application.
Raïch-Regué D; Glancy M; Thomson AW
Immunol Lett; 2014 Oct; 161(2):216-21. PubMed ID: 24316407
[TBL] [Abstract][Full Text] [Related]
10. Regulatory dendritic cells: profiling, targeting, and therapeutic application.
Thomson AW; Ezzelarab MB
Curr Opin Organ Transplant; 2018 Oct; 23(5):538-545. PubMed ID: 30036199
[TBL] [Abstract][Full Text] [Related]
11. Regulatory Dendritic Cells, T Cell Tolerance, and Dendritic Cell Therapy for Immunologic Disease.
Ness S; Lin S; Gordon JR
Front Immunol; 2021; 12():633436. PubMed ID: 33777019
[TBL] [Abstract][Full Text] [Related]
12. Microchimerism, dendritic cell progenitors and transplantation tolerance.
Thomson AW; Lu L; Murase N; Demetris AJ; Rao AS; Starzl TE
Stem Cells; 1995 Nov; 13(6):622-39. PubMed ID: 8590864
[TBL] [Abstract][Full Text] [Related]
13. Donor bone marrow infusion in deceased and living donor renal transplantation.
Ciancio G; Burke GW; Moon J; Garcia-Morales R; Rosen A; Esquenazi V; Mathew J; Jin Y; Miller J
Yonsei Med J; 2004 Dec; 45(6):998-1003. PubMed ID: 15627290
[TBL] [Abstract][Full Text] [Related]
14. Infusion of stably immature monocyte-derived dendritic cells plus CTLA4Ig modulates alloimmune reactivity in rhesus macaques.
Zahorchak AF; Kean LS; Tokita D; Turnquist HR; Abe M; Finke J; Hamby K; Rigby MR; Larsen CP; Thomson AW
Transplantation; 2007 Jul; 84(2):196-206. PubMed ID: 17667811
[TBL] [Abstract][Full Text] [Related]
15. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
16. Dendritic cells and regulation of alloimmune responses: relevance to outcome and therapy of organ transplantation.
Abe M; Metes D; Thomson AW
Expert Rev Clin Immunol; 2005 Sep; 1(3):419-30. PubMed ID: 20476992
[TBL] [Abstract][Full Text] [Related]
17. Tolerogenic dendritic cells and negative vaccination in transplantation: from rodents to clinical trials.
Moreau A; Varey E; Bériou G; Hill M; Bouchet-Delbos L; Segovia M; Cuturi MC
Front Immunol; 2012; 3():218. PubMed ID: 22908013
[TBL] [Abstract][Full Text] [Related]
18. Prevention of acute and chronic allograft rejection by combinations of tolerogenic dendritic cells.
Huang YL; Wang YZ; Chen JB; Wang F; Kang XP; Xia JJ; Lan TS; Xie BY; Ekberg H; Wang XM; Qi ZQ
Scand J Immunol; 2011 Feb; 73(2):91-101. PubMed ID: 21198749
[TBL] [Abstract][Full Text] [Related]
19. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections.
Duncan MD; Wilkes DS
Proc Am Thorac Soc; 2005; 2(5):449-55. PubMed ID: 16322599
[TBL] [Abstract][Full Text] [Related]
20. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation.
Turnquist HR; Thomson AW
Curr Opin Organ Transplant; 2008 Aug; 13(4):350-7. PubMed ID: 18685329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]